Search

everythinglearnresearchcommunity

for

Search:↓

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Microneedling and PRP are generally safe but can cause mild skin issues; serious problems are rare.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New treatments for lupus show promise, but more research is needed, especially for children.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Microneedling is generally safe but can cause minor, temporary side effects and requires caution for some patients.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

The cat's skin condition improved with treatment, but underlying health issues must be addressed.

Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.